High rates of appropriate therapy in non-ischaemic cardiomyopathy patients with implantable cardioverter-defibrillators over a 5-year follow up

Introduction: The benefit of implantable cardioverter defibrillators in non-ischaemic dilated cardiomyopathy (NIDCM) has been convincingly established, however, recent data has suggested a decline in device therapy rates. Evaluation in device therapy between primary and secondary prevention is also...

Full description

Saved in:
Bibliographic Details
Published inEuropean journal of arrhythmia & electrophysiology Vol. 5; p. 200
Main Authors Pooranachandran, V, Vali, Z, Ng, G A
Format Journal Article
LanguageEnglish
Published Reading Touch Medical Media Limited 01.01.2019
Subjects
Online AccessGet full text

Cover

Loading…